October 28, 1996

Treatment Guidelines for Patients With Thyroid Nodules and Well-Differentiated Thyroid Cancer

Author Affiliations

From the Division of Endocrinology, Diabetes, and Hypertension, University of Southern California School of Medicine, Los Angeles (Dr Singer); the Divisions of Endocrinology, The Johns Hopkins University School of Medicine (Drs Cooper and Ladenson) and Mount Sinai Hospital (Dr Cooper), Baltimore, Md; the Thyroid Unit, Massachusetts General Hospital, Boston (Dr Daniels); the Division of Endocrinology, University of California, San Francisco, School of Medicine (Dr Greenspan); the Division of Endocrinology, University of Miami School of Medicine, Miami, Fla (Dr Levy); the Division of Endocrinology, University of Massachusetts Medical School, Worchester (Dr Braverman); the Department of Surgery, Mt Zion Medical Center, University of California, San Francisco, School of Medicine (Dr Clark); the Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, Calif (Dr McDougall); the Division of Endocrinology, University of Kentucky, Lexington (Dr Ain); and Endocrine Associates of Dallas, Dallas, Tex (Dr Dorfman).

Arch Intern Med. 1996;156(19):2165-2172. doi:10.1001/archinte.1996.00440180017002

A set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with thyroid nodules or thyroid cancer was developed by consensus by an 11-member Standards of Care Committee (the authors of the article) of the American Thyroid Association, New York, NY. The participants were selected by the committee chairman and by the president of the American Thyroid Association based on their clinical experience. The committee members represented different geographic areas within the United States, to reflect different practice patterns. The guidelines were developed based on the expert opinion of the committee participants, as well as on previously published information. Each committee participant was initially assigned to write a section of the document and to submit it to the committee chairman, who revised and assembled the sections into a complete draft document, which was then circulated among all committee members for further revision. Several of the committee members further revised and refined the document, which was then submitted to the entire membership of the American Thyroid Association for written comments and suggestions, many of which were incorporated into a final draft document, which was reviewed and approved by the Executive Council of the American Thyroid Association.

Arch Intern Med. 1996;156:2165-2172